Engineered Probiotic Saccharomyces boulardii Produces Functional Insulin With Long-Acting Effect in Mice Model
{{output}}
Diabetes mellitus affects over 500 million people globally, with current insulin therapies relying on subcutaneous injections that compromise the liver's natural role in glucose regulation and suffer from poor patient compliance. Oral insulin delivery offers ... ...
